Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.20 | 31.79 | 44.82 | 33.45 | 47.47 | 56.17 | 61.23 | 43.14 | 48.92 | 53.81 | 89.60 | 44.88 |
| Expenses | 32.58 | 29.51 | 37.74 | 31.79 | 41.37 | 47.44 | 46.64 | 39.88 | 43.88 | 47.66 | 67.46 | 41.94 |
| Operating Profit | 8.62 | 2.28 | 7.08 | 1.66 | 6.10 | 8.73 | 14.59 | 3.26 | 5.04 | 6.15 | 22.14 | 2.94 |
| OPM % | 20.92% | 7.17% | 15.80% | 4.96% | 12.85% | 15.54% | 23.83% | 7.56% | 10.30% | 11.43% | 24.71% | 6.55% |
| Other Income | 0.49 | 2.96 | 0.47 | 2.57 | 5.16 | 1.73 | 1.70 | 2.56 | 6.66 | 1.53 | 0.49 | 2.90 |
| Interest | 1.51 | 1.60 | 1.32 | 1.73 | 0.31 | 1.40 | 1.60 | 1.53 | 1.44 | 1.15 | 1.44 | 0.88 |
| Depreciation | 0.82 | 0.81 | 0.93 | 0.85 | 0.61 | 0.81 | 0.85 | 0.84 | 0.86 | 0.94 | 0.98 | 1.09 |
| Profit before tax | 6.78 | 2.83 | 5.30 | 1.65 | 10.34 | 8.25 | 13.84 | 3.45 | 9.40 | 5.59 | 20.21 | 3.87 |
| Tax % | 24.93% | 38.16% | 30.57% | 93.33% | 16.73% | 32.00% | 26.23% | 34.49% | 14.47% | 22.90% | 26.37% | 48.84% |
| Net Profit | 5.09 | 1.74 | 3.68 | 0.11 | 8.61 | 5.61 | 10.22 | 2.27 | 8.04 | 4.31 | 14.88 | 1.96 |
| EPS in Rs | 1.35 | 0.83 | 1.03 | 0.38 | 2.46 | 1.70 | 2.97 | 0.87 | 2.34 | 1.27 | 4.15 | 0.83 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21 | 27 | 51 | 82 | 53 | 68 | 114 | 140 | 154 | 198 | 235 | 237 |
| Expenses | 25 | 28 | 45 | 75 | 53 | 63 | 104 | 122 | 130 | 167 | 198 | 201 |
| Operating Profit | -4 | -1 | 6 | 7 | 0 | 5 | 10 | 18 | 24 | 32 | 37 | 36 |
| OPM % | -19% | -2.0% | 11% | 9% | 0.8% | 8% | 9% | 13% | 16% | 16% | 16% | 15% |
| Other Income | 2 | 1 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 11 | 11 | 12 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 | 6 | 5 | 6 | 5 |
| Depreciation | 10 | 10 | 2 | 2 | 2 | 2 | 2 | 4 | 3 | 3 | 4 | 4 |
| Profit before tax | -12 | -9 | 6 | 9 | 2 | 5 | 10 | 12 | 19 | 34 | 39 | 39 |
| Tax % | -4% | -5% | 16% | 55% | 48% | 27% | 35% | 31% | 30% | 28% | 24% | |
| Net Profit | -11 | -9 | 5 | 4 | 1 | 4 | 6 | 8 | 14 | 25 | 30 | 29 |
| EPS in Rs | -3.89 | -3.09 | 1.72 | 1.15 | 0.25 | 1.09 | 2.17 | 3.08 | 4.17 | 7.63 | 8.63 | 8.59 |
| Dividend Payout % | -0% | -0% | 13% | 20% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 27% | 28% | 19% | 14% | ||
| Compounded Profit Growth | 16% | 55% | 38% | 7% | ||
| Stock Price CAGR | 27% | 22% | 21% | 28% | ||
| Return on Equity | 5% | 9% | 10% | 11% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 14 | 15 | 15 | 15 | 16 | 16 | 16 | 16 | 35 |
| Reserves | 107 | 95 | 88 | 98 | 106 | 103 | 112 | 124 | 136 | 160 | 186 | 245 |
| Borrowings | -0 | 0 | 1 | 1 | 9 | 13 | 15 | 20 | 22 | 32 | 49 | 89 |
| Other Liabilities | 7 | 8 | 11 | 15 | 13 | 12 | 61 | 50 | 46 | 32 | 61 | 89 |
| Total Liabilities | 127 | 117 | 113 | 128 | 144 | 143 | 203 | 210 | 220 | 240 | 313 | 458 |
| Fixed Assets | 9 | 42 | 33 | 33 | 32 | 32 | 30 | 65 | 64 | 62 | 64 | 67 |
| CWIP | -0 | -0 | 1 | 3 | 20 | 30 | 65 | 3 | 4 | 6 | 47 | 140 |
| Investments | 72 | 49 | 53 | 56 | 53 | 52 | 60 | 71 | 62 | 72 | 72 | 75 |
| Other Assets | 46 | 25 | 26 | 35 | 38 | 30 | 47 | 71 | 90 | 100 | 129 | 176 |
| Total Assets | 127 | 117 | 113 | 128 | 144 | 143 | 203 | 210 | 220 | 240 | 313 | 458 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -8 | 17 | 1 | 1 | 0 | 4 | 46 | 6 | 3 | -2 | 18 | 24 |
| Cash from Investing Activity | -31 | -20 | -2 | -4 | -14 | -10 | -38 | -15 | 8 | -8 | -40 | -100 |
| Cash from Financing Activity | -0 | 0 | -0 | 6 | 17 | 1 | 2 | 7 | -1 | 9 | 13 | 82 |
| Net Cash Flow | -39 | -2 | -0 | 2 | 3 | -5 | 10 | -2 | 10 | -1 | -9 | 6 |
| Free Cash Flow | -10 | -26 | -0 | -2 | -19 | -6 | 9 | -2 | -1 | -8 | -29 | -76 |
| CFO/OP | 430% | -442% | -202% | 25% | 60% | 1,598% | 877% | 79% | 39% | 23% | 82% | 92% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 243 | 286 | 196 | 148 | 86 | 109 | 122 | 132 | 142 | 149 | 156 | 186 |
| Inventory Days | 124 | 110 | 84 | 39 | 36 | 70 | 35 | 28 | 10 | 18 | 53 | 33 |
| Days Payable | 124 | 154 | 184 | 108 | 33 | 89 | 525 | 239 | 200 | 118 | 189 | 230 |
| Cash Conversion Cycle | 243 | 241 | 96 | 79 | 89 | 89 | -367 | -79 | -48 | 50 | 20 | -11 |
| Working Capital Days | 197 | 234 | 115 | 93 | 37 | 22 | -223 | -40 | -4 | 30 | 56 | 49 |
| ROCE % | -10% | -9% | 5% | 6% | 1% | 3% | 6% | 10% | 13% | 16% | 13% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.23% | 69.23% | 69.23% | 69.23% | 69.23% | 69.23% | 69.23% | 69.23% | 63.77% | 63.77% | 63.77% | 63.77% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
| Public | 30.78% | 30.76% | 30.77% | 30.77% | 30.77% | 30.76% | 30.77% | 30.77% | 36.22% | 36.23% | 36.22% | 36.11% |
| No. of Shareholders | 9,002 | 9,062 | 9,525 | 9,620 | 9,920 | 10,139 | 9,749 | 10,379 | 10,929 | 12,043 | 11,785 | 12,627 |
Fundamentals
Market Cap₹ 747 Cr.
Current Price₹ 217
Stock P/E24.8
Book Value₹ 80.0
ROCE13.4 %
ROE10.6 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)14%
Compounded Profit Growth (TTM)7%
Consolidated figures.
Valuation
Market capRs 764 Cr
Enterprise valueRs 836 Cr
P/E (TTM)25.42x
Price to book2.73x
Price to sales3.22x
EV / EBITDA17.47x
EV / EBIT19.01x
EV / sales3.52x
Price to cash flow31.88x
Earnings yield3.93%
P/E, 3-year average15.36x
P/B, 3-year average1.57x
P/E, 5-year average14.71x
P/B, 5-year average1.26x
Profitability
Operating margin (excl. other income)15.85%
Operating margin (incl. other income)20.63%
EBITDA margin20.17%
Pre-tax margin16.47%
Net profit margin12.67%
Net margin, latest quarter6.48%
ROE12.52%
ROCE14.50%
ROA7.83%
ROE, 3-year average11.84%
ROCE, 3-year average15.04%
ROA, 3-year average7.95%
ROE, 5-year average9.65%
ROCE, 5-year average12.53%
ROA, 5-year average6.46%
ROIC (approx.)9.55%
Tax rate23.69%
Other income / net worth4.02%
Growth
Sales growth (latest year)18.73%
Profit growth (latest year)13.00%
Sales CAGR, 3 years19.04%
Sales CAGR, 5 years28.05%
Profit CAGR, 3 years42.39%
Profit CAGR, 5 years52.40%
Sales growth QoQ-49.91%
Profit growth QoQ-79.96%
Sales growth YoY (latest quarter)4.03%
Profit growth YoY (latest quarter)-3.96%
Per share
EPS (TTM)Rs 8.60
EPS (latest year)Rs 8.63
EPS (latest quarter)Rs 0.83
EPS, 3-year averageRs 11.44
EPS, 5-year averageRs 9.15
Book value per shareRs 79.99
Sales per shareRs 67.85
Cash flow per shareRs 6.85
Free cash flow per shareRs -21.74
Efficiency
Asset turnover0.51x
Fixed asset turnover3.53x
Inventory turnover11.88x
Inventory days31 days
Debtor days186 days
Debtors turnover1.96x
Creditor days230 days
Cash conversion cycle-11 days
Working capital days49 days
Leverage
Total debtRs 89 Cr
Cash and bankRs 17 Cr
Net debtRs 72 Cr
Debt to equity0.32x
Net debt / EBITDA1.50x
Interest coverage8.96x
Current ratio (filing 2026-03-31)1.83x
Quick ratio (filing 2026-03-31)1.73x
Trade payables (filing 2026-03-31)Rs 80 Cr
Owners' fund to total sources61.09%
Debt to assets19.38%
Cash flow
Cash from Operating Activity (latest year)Rs 24 Cr
Cash from Investing Activity (latest year)Rs -100 Cr
Cash from Financing Activity (latest year)Rs 82 Cr
Net Cash Flow (latest year)Rs 6 Cr
Free cash flow (latest year)Rs -76 Cr
FCFE (approx.: FCF + change in debt)Rs -37 Cr
Cash from ops / profit, 5 years0.59x
Sales to cash flow9.83x
Statement figures
Net sales (TTM)Rs 237 Cr
Net sales (latest year)Rs 235 Cr
Sales (latest quarter)Rs 45 Cr
Operating profit excl. other income (latest year)Rs 37 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 12 Cr
EBITDA (TTM)Rs 48 Cr
PBDT (TTM)Rs 43 Cr
Profit before tax (TTM)Rs 39 Cr
Tax (latest year)Rs 9 Cr
Net profit (TTM)Rs 30 Cr
Net profit (latest year)Rs 30 Cr
Net profit (latest quarter)Rs 3 Cr
Depreciation (TTM)Rs 4 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 5 Cr
Cost of goods sold (latest year)Rs 137 Cr
Total expenditure (latest year)Rs 198 Cr
Total income (latest year)Rs 247 Cr
Share capitalRs 35 Cr
ReservesRs 245 Cr
Shareholders' fundsRs 280 Cr
Total assetsRs 458 Cr
Net blockRs 67 Cr
Capital work in progressRs 140 Cr
InvestmentsRs 75 Cr
ReceivablesRs 120 Cr
InventoryRs 12 Cr
Other liabilitiesRs 89 Cr
Shares outstanding (crore)3.50
Ownership
Promoter holding63.77% (-5.46 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 25.4 is at the 14th percentile of its own 8.4-year range
(median 46.4, low 16.7, high 339.5).
P/B 2.73 is at the 65th percentile (median 2.23).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | KILITCH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +0.6% | -2.8% | +3.4 pts |
| 1 month | +28.1% | -6.8% | +34.9 pts |
| 3 months | +16.0% | -7.6% | +23.6 pts |
| 6 months | +75.6% | +0.4% | +75.2 pts |
| 1 year | +26.5% | -9.9% | +36.4 pts |
| 2 years | +19.0% | -13.6% | +32.5 pts |
| 3 years | +75.5% | +14.2% | +61.3 pts |
| 5 years | +160.2% | +27.9% | +132.3 pts |
Red flags
F-score 3 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹45 Cr +4.0% vs Jun 2025.
Net profit ₹2 Cr -13.7%.
Against our estimate for Jun 2026: sales -14.1%, profit -69.3% miss. Our estimate for Sep 2026: sales Rs 61 Cr, profit Rs 7 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-03-24 | Bonus 1:1 | 0.5000 |
| 2025-07-15 | Rights 2:23 @ Premium Rs 347/- | |
| 2024-09-19 | Annual General Meeting | |
| 2023-09-21 | Annual General Meeting | |
| 2022-09-20 | Annual General Meeting | |
| 2021-09-21 | Annual General Meeting | |
| 2020-09-22 | Annual General Meeting | |
| 2019-09-20 | Annual General Meeting/Dividend - Rs 0.5 Per Share | |
| 2018-09-18 | Annual General Meeting/Dividend Re 0.50 Per Share | |
| 2017-09-20 | Annual General Meeting | |
| 2016-09-21 | Annual General Meeting | |
| 2015-09-21 | Annual General Meeting | |
| 2014-09-23 | Annual General Meeting | |
| 2013-09-24 | Annual General Meeting | |
| 2012-09-24 | Special Interim Dividend Rs.30/- Per Share | |
| 2012-09-24 | Inferred from price: close fell to 0.601x overnight, no NSE action on record | 0.6000 |
| 2011-08-18 | Annual General Meeting And Dividend Re.1/- Per Share | |
| 2010-10-14 | Dividend-Re.1/- Per Share |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 25perc in previous 1 month
Quick answers
What is the market cap of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd (KILITCH) has a market capitalisation of Rs 747 Cr. at the 2026-10-01 close.
What is the P/E ratio of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd trades at a P/E of 24.8 on trailing twelve-month profit, at the 2026-10-01 close.
What were Kilitch Drugs (India) Ltd's latest quarterly results?
In the Jun 2026 quarter, Kilitch Drugs (India) Ltd sales was Rs 45 Cr (+4.0% vs Jun 2025) and net profit was Rs 2 Cr.
What is the 52-week high and low of Kilitch Drugs (India) Ltd?
The 52-week high is Rs 232.50 and the 52-week low is Rs 117.25.